Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carson Lam

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
JMIR Formative Research|August 16, 2021
Semisupervised Deep Learning Techniques for Predicting Acute Respiratory Distress Syndrome From Time-Series Clinical Data: Model Development and Validation StudyCarson Lam, Chak Foon Tso, Abigail Green-Saxena, et al.
Clinical Therapeutics|April 18, 2021
Machine Learning as a Precision-Medicine Approach to Prescribing COVID-19 Pharmacotherapy with Remdesivir or CorticosteroidsCarson Lam, Anna Siefkas, Nicole S Zelin, et al.
Journal of Clinical Medicine|December 1, 2020
Is Machine Learning a Better Way to Identify COVID-19 Patients Who Might Benefit from Hydroxychloroquine Treatment?-The IDENTIFY TrialHoyt Burdick, Carson Lam, Samson Mataraso, et al.
Computers in Biology and Medicine|August 18, 2020
Prediction of respiratory decompensation in Covid-19 patients using machine learning: The READY trialHoyt Burdick, Carson Lam, Samson Mataraso, et al.
Plos One|March 17, 2021
COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patientsMark Stewart, Carla Rodriguez-Watson, Adem Albayrak, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
JMIR Formative Research|August 16, 2021
Semisupervised Deep Learning Techniques for Predicting Acute Respiratory Distress Syndrome From Time-Series Clinical Data: Model Development and Validation StudyCarson Lam, Chak Foon Tso, Abigail Green-Saxena, et al.
Clinical Therapeutics|April 18, 2021
Machine Learning as a Precision-Medicine Approach to Prescribing COVID-19 Pharmacotherapy with Remdesivir or CorticosteroidsCarson Lam, Anna Siefkas, Nicole S Zelin, et al.
Journal of Clinical Medicine|December 1, 2020
Is Machine Learning a Better Way to Identify COVID-19 Patients Who Might Benefit from Hydroxychloroquine Treatment?-The IDENTIFY TrialHoyt Burdick, Carson Lam, Samson Mataraso, et al.
Computers in Biology and Medicine|August 18, 2020
Prediction of respiratory decompensation in Covid-19 patients using machine learning: The READY trialHoyt Burdick, Carson Lam, Samson Mataraso, et al.
Plos One|March 17, 2021
COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patientsMark Stewart, Carla Rodriguez-Watson, Adem Albayrak, et al.
Pageof 2